Samalin Investment Counsel’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,618
Closed -$292K 284
2023
Q1
$292K Sell
3,618
-193
-5% -$15.7K 0.18% 168
2022
Q4
$296K Sell
3,811
-9
-0.2% -$729 0.19% 153
2022
Q3
$308K Buy
3,820
+5
+0.1% +$449 0.23% 134
2022
Q2
$342K Buy
3,815
+3
+0.1% +$304 0.24% 130
2022
Q1
$423K Buy
3,812
+358
+10% +$37.8K 0.26% 120
2021
Q4
$357K Buy
3,454
+278
+9% +$32.2K 0.21% 148
2021
Q3
$398K Sell
3,176
-8
-0.3% -$1.03K 0.26% 127
2021
Q2
$395K Buy
3,184
+52
+2% +$6.53K 0.26% 133
2021
Q1
$370K Buy
3,132
+227
+8% +$26.6K 0.25% 131
2020
Q4
$340K Sell
2,905
-223
-7% -$24.5K 0.26% 138
2020
Q3
$325K Buy
3,128
+437
+16% +$43.9K 0.29% 110
2020
Q2
$246K Buy
2,691
+153
+6% +$14.7K 0.26% 129
2020
Q1
$228K Sell
2,538
-615
-20% -$65.4K 0.31% 101
2019
Q4
$357K Buy
+3,153
New +$346K 0.3% 95

Other funds holding MDT

Samalin Investment Counsel's MDT Position: Q2 2023 in Review

Samalin Investment Counsel sold out of Medtronic (MDT) in Q2 2023, closing a stake of 3,618 shares — an estimated $292K sold.

Samalin Investment Counsel first reported a position in MDT in Q4 2019 and held it in 14 quarters. The position peaked at $423K in Q1 2022. 2,057 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Samalin Investment Counsel reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
  • Samalin Investment Counsel sold 3,618 Medtronic shares in Q2 2023, an estimated $292K.
  • Samalin Investment Counsel first reported a position in Medtronic in Q4 2019 and held it in 14 quarters.
  • Samalin Investment Counsel's Medtronic position peaked at $423K in Q1 2022.
  • 2,057 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Samalin Investment Counsel's 13F filing for Q2 2023, filed 3 Aug 2023.